Search

Author/Creator Stephens, C.

2. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Issue 1 (13th November 2014)

Authors:
Robles‐Diaz, M.; Gonzalez‐Jimenez, A.; Medina‐Caliz, I.; Stephens, C.; García‐Cortes, M.; García‐Muñoz, B.; Ortega‐Alonso, A.; Blanco‐Reina, E.; Gonzalez‐Grande, R.; Jimenez‐Perez, M.; Rendón, P.; Navarro, J. M.; Gines, P.; Prieto, M.; Garcia‐Eliz, M.; Bessone, F.; Brahm, J. R.; Paraná, R.; Lucen...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 41:Issue 1(2015)
Page Start:
116
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Phase I modular study of AZD6738, a novel oral, potent and selective ataxia telangiectasia Rad3-related (ATR) inhibitor in combination (combo) with carboplatin, olaparib or durvalumab in patients (pts) with advanced cancers. (December 2016)

Authors:
Yap, T.A.; Krebs, M.G.; Postel-Vinay, S.; Bang, Y.J.; El-Khoueiry, A.; Abida, W.; Harrington, K.; Sundar, R.; Carter, L.; Castanon-Alvarez, E.; Im, S.A.; Berges, A.; Khan, M.; Stephens, C.; Ross, G.; Soria, J.C.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S2
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗